Moleculin Biotech, Inc. — Form 8-K
Filed August 31, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Moleculin Biotech filed an 8-K on 2026-08-31 disclosing presentation materials (59 slide exhibits) under Regulation FD Item 7.01. No specific financial figures, counterparties, transactions, dollar amounts, percentages, or share counts are disclosed in this filing. The filing appears to be purely procedural disclosure of investor presentation content.
Why this rating
Routine Reg FD disclosure of presentation slides. No material transaction, financing, or business event disclosed. Administrative filing only.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.